Scared of needles? Here’s some good news: in the future, you might be able to rub a vaccination into your skin.
Researchers at the University of Auckland have found a way to deliver medicines through skin, which is usually an impervious barrier.
“It’s like wearing a raincoat – it stops the water getting in, we go out in the rain and we don’t melt, stops all those nasty chemicals getting through our skin most of the time,” says Dr Dareen Svirskis, senior pharmacy lecturer.
“This is potentially a breakthrough peptide technology,” says Professor Julia Kennedy, head of Auckland University’s School of Pharmacy. “Obtaining a biological response from applying substances through the skin is very difficult to achieve and approaches can be extremely expensive.”
For the past four years senior pharmacy lecturer Zimei Wu has been supervising research by PhD candidate Travis Badenhorst, with the assistance of Dr Svirskis. Dr Svirskis says their breakthrough allows drugs to be delivered directly to cells through the skin.
“What Zimei’s envisaged is to develop this tiny little nano formulation, these tiny little nano carriers. We can put the peptide inside that, and what’s amazing is that we’ve seen for the first time that it can be delivered to the skin, it’ll pass through the skin and it’ll be taken up in cells.
“We’ve seen this in cell cultures for the first time biologically, and we’ve seen this in human skin as well.”
The research was financially backed by the Government and Auckland-based skincare company Snowberry, which has applied for a patent on the process.
And there’s a good reason a cosmetics company backed the research – Dr Svirskis says the technology is perfect for anti-aging products, and outperformed every existing commercial product they compared it to during testing.
“The cosmetic route’s a lot faster to get a product to people. When we start talking about medical devices or vaccine delivery, then yes, there’s years of testing they have to go through to ensure the safety and efficacy of these products.”
The Latest on: Peptide technology
via Google News
The Latest on: Peptide technology
- Diabetic Ketoacidosis Treatments Market 2020 Industry Size, Top Manufacturers, Emerging Technologies, Sales Revenue, and Forecast by 2025on June 26, 2020 at 6:12 am
Final Report will add the analysis of the impact of COVID-19 on this industry” Global “Diabetic Ketoacidosis Treatments Market” report studies the market in-depth and provides an all-encompassing ...
- Endocrine Peptides Test Market Surge at 8.1% CAGR, Decline in Growth Likely Due to Coronavirus Outbreak, Says Market.uson June 26, 2020 at 1:47 am
The report yields a primary overview of the endocrine peptides test industry including its definition, economic outlook, key-supply demand analysis and manufacturing technology. The report also delves ...
- Rice Genetically Altered to Contain Anti-Hypertensive Peptides – Eating a Spoonful Lowers Blood Pressureon June 24, 2020 at 7:16 pm
In the future, taking your blood pressure medication could be as simple as eating a spoonful of rice. This “treatment” could also have fewer side effects than ...
- Sarepta Therapeutics, Inc. (SRPT) CEO Doug Ingram Presents at Bank of America Napa Healthcare Conference (Transcript)on June 24, 2020 at 3:53 pm
SRPT) Bank of America Napa Healthcare Conference June 24, 2020 12:30 PM ET Company Participants Doug Ingram - President & ...
- Palatin Technologies to Develop PL8177 as a Potential Treatment for COVID-19 and Associated Lung Complicationson June 23, 2020 at 5:27 am
Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic ...
- Paragonix Technologies Announces Appointment of Alexander K. Arrow, MD, CFA to the Board of Directorson June 22, 2020 at 5:39 am
Paragonix Technologies, Inc. a commercial stage company and leader in organ preservation and transport technology, today announced that Alexander K. Arrow, MD, CFA has joined its Board of Directors.
- New Data Show Theratechnologies’ SORT1+ Technology is Effective in Many Treatment-Resistant Cancerson June 22, 2020 at 4:30 am
Peptide-drug conjugates TH1902 and TH1904 show significant reduction in the formation of vasculogenic mimicry by targeting the sortilin receptor Curcumin shows increased anticancer activity when ...
- Synthetic peptide could be an effective COVID-19 treatment and SARS-CoV-2 vaccineon June 21, 2020 at 10:48 pm
Ligandal has proven the efficacy of its COVID peptide in computer modelling and simulation studies, and is currently validating the preclinical efficacy of its technology. Vaccines currently in ...
- Plant Health Care gets EPA approval for 'PHC398' peptideon June 16, 2020 at 1:17 am
Agricultural biological products company Plant Health Care announced on Tuesday that the US Environmental Protection Agency (EPA) has approved its application for the novel peptide product 'PHC398'.
- Treos Bio Forms New Subsidiary to Develop a Preventive COVID-19 Peptide Vaccineon June 15, 2020 at 6:16 pm
Treos Bio Limited, a clinical stage biopharma company developing targeted peptide cancer immunotherapies, today said that it has developed and successfully tested in silico a preventive COVID-19 ...
via Bing News